Studies have shown that GPC3 is a reliable marker for hepatocellular carcinoma, with a sensitivity and specificity exceeding those of the alpha-fetoprotein and hepatocyte paraffin tests. The gene discussed is AFP; the disease is hepatocellular carcinoma.